Harvard Bioscience, Inc. logo
Harvard Bioscience Announces First Quarter 2021 Financial Results
May 06, 2021 07:15 ET | Harvard Bioscience, Inc.
Sales effectiveness, pre-clinical product demand and disciplined cost management result in improved revenues and margins Revenue up 14% as sales momentum from Q4’20 continuesPre-clinical product...
Harvard Bioscience, Inc. logo
Harvard Bioscience Schedules First Quarter 2021 Earnings Conference Call for May 6, 2021 at 8:00 AM ET
April 19, 2021 16:55 ET | Harvard Bioscience, Inc.
HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May...
Harvard Bioscience, Inc. logo
Harvard Bioscience Announces Fourth Quarter 2020 Financial Results
March 10, 2021 07:00 ET | Harvard Bioscience, Inc.
Revenue returns to pre-Covid19 levels on strong CRO/pharma salesOperating margin increased year-over-year on GAAP and an adjusted basisNew debt facility significantly reduces annual interest expense ...
Harvard Bioscience, Inc. logo
Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
February 18, 2021 17:24 ET | Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2020 before the market opens on...
Harvard Bioscience, Inc. logo
Harvard Bioscience Announces New Credit Facility
December 22, 2020 18:05 ET | Harvard Bioscience, Inc.
Improves liquidity and operating flexibilitySignificantly reduces borrowing costsSupports ongoing transformation to profitable growth platform HOLLISTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) --...
Harvard Bioscience, Inc. logo
Harvard Bioscience to attend Benchmark’s 9th Annual Discovery One-on-One Conference
November 16, 2020 16:35 ET | Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will participate in...
Harvard Bioscience, Inc. logo
Harvard Bioscience Announces Third Quarter 2020 Financial Results
November 05, 2020 07:00 ET | Harvard Bioscience, Inc.
Operating margin up year-over-year on GAAP and adjusted basisRevenue improved sequentially with solid CRO/pharma demand and academic labs reopeningGenerated positive operating cash flow in Q3 with...
Harvard Bioscience, Inc. logo
Harvard Bioscience Schedules Third Quarter 2020 Earnings Conference Call for November 5, 2020 at 8:00 AM ET
October 20, 2020 16:45 ET | Harvard Bioscience, Inc.
HOLLISTON, MA., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2020 before the market opens on...
Harvard Bioscience, Inc. logo
Harvard Bioscience to Present at Singular Research Compelling Values Webinar
September 16, 2020 16:30 ET | Harvard Bioscience, Inc.
HOLLISTON, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, President and CEO, will present at the Singular Research Compelling...
Harvard Bioscience, Inc. logo
Harvard Bioscience Announces Second Quarter 2020 Financial Results
August 05, 2020 07:00 ET | Harvard Bioscience, Inc.
Operating Income up sequentially and year-over-year on both GAAP and adjusted basisCost reduction programs offset expected declines in Academic marketsNet Debt reduced by $2.2 million in Q2 ...